Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Rat (Rattus) SOCS6 Antibodies:
anti-Human SOCS6 Antibodies:
anti-Mouse (Murine) SOCS6 Antibodies:
Go to our pre-filtered search.
Four new members of the SOCS (show CISH Antibodies) family of molecules in rainbow trout (Oncorhynchus mykiss), CISH (show CISH Antibodies) and SOCS6, 7 and 9, are described for the first time in this species
Results indicate that similar to PTEN (show PTEN Antibodies) pseudogene (PTENP1), suppressor of cytokine signaling 6 protein (SOCS6) expression was also significantly lower in esophageal squamous cell carcinoma (ESCC) samples.
our results describe for the first time the role of miR (show MLXIP Antibodies)-494-3p during normal hematopoietic stem/progenitor cells differentiation and suggest that its increased expression, and the subsequent downregulation of its target SOCS6, might contribute to the megakaryocyte hyperplasia commonly observed in primary myelofibrosis patients.
miR (show MLXIP Antibodies)-142-3p regulates NPC (show NPC1 Antibodies) development by down-regulating SOCS6 expression and suggest that modulation of miR (show MLXIP Antibodies)-142-3p expression could be a therapeutic strategy for NPC (show NPC1 Antibodies)
Stage-independent downregulation of SOCS2 (show SOCS2 Antibodies) and SOCS6 correlate with disease-free survival in colorectal cancer.
Studied both the function of upregulated miR (show MLXIP Antibodies)-424-5p in pancreatic cancer and how downstream suppressor of cytokine-induced signaling 6 (SOCS6) is negatively regulated by miR (show MLXIP Antibodies)-424-5p.
miR-17-5p might function as a pro-proliferative factor by repressing SOCS6 in gastric cancer
SOCS2 (show SOCS2 Antibodies) and SOCS6 expression are remarkably reduced in hepatocellular carcinoma and correlate with aggressive tumor progression and poor prognosis
Results show that SOCS6 forms complex with DRP1 (show CRMP1 Antibodies) and the mitochondrial phosphatase PGAM5 (show PGAM5 Antibodies), attenuates DRP1 (show CRMP1 Antibodies) phosphorylation, and promotes DRP1 (show CRMP1 Antibodies) mitochondrial translocation.
SOCS6 negatively regulates Flt3 (show FLT3 Antibodies) activation, the downstream Erk (show EPHB2 Antibodies) signaling pathway, and cell proliferation.
Reduced copy number and mRNA expression of SOCS6 are associated with disease recurrence in primary lung squamous cell carcinoma and may be useful prognostic biomarkers.
Our results show that endogenous Cul5 (show CUL5 Antibodies) suppresses epithelial cell transformation by several pathways, including inhibition of Src (show SRC Antibodies)-Cas (show CTNND1 Antibodies)-induced ruffling through SOCS6
SOCS-6 binds to insulin receptor substrate 4 (show IRS4 Antibodies), and mice lacking the SOCS-6 gene exhibit mild growth retardation(SOCS-6)
SOCS4 expression, in contrast, does not appear to be EPO (show EPO Antibodies) inducible.SOCS4 is ineffective at counteracting EPO (show EPO Antibodies)-mediated events.
SOCS6 has a role as a negative regulator of receptor tyrosine kinases
SOCS-6 expression is induced by insulin, which regulates its binding to the p85 monomer of phosphoinositide 3-kinase
TH1 (show HAND1 Antibodies)-specific chromatin structure is created by early recruitment of Swi (show SMARCA1 Antibodies)-SNF (show SNRPA Antibodies) complexes and nucleosome remodeling dependent on Stat4 (show STAT4 Antibodies).
The protein encoded by this gene contains a SH2 domain and a CIS homolog domain. The protein thus belongs to the cytokine-induced STAT inhibitor (CIS), also known as suppressor of cytokine signaling (SOCS) or STAT-induced STAT inhibitor (SSI), protein family. CIS family members are known to be cytokine-inducible negative regulators of cytokine signaling. The expression of this gene can be induced by GM-CSF and EPO in hematopoietic cells. A high expression level of this gene was found in factor-independent chronic myelogenous leukemia (CML) and erythroleukemia (HEL) cell lines.
suppressor of cytokine signaling 6
, suppressor of cytokine signaling
, hypothetical protein LOC100124796
, STAT induced STAT inhibitor-4
, cytokine-inducible SH2 protein 4
, suppressor of cytokine signaling 4
, SH2 domain containing SOCS box protein SOCS6
, cytokine inducible SH2-containing protein 4
, cytokine inducible SH2-containing protein CIS4